Assessment of the economic impact of Belimumab for the treatment of systemic lupus erithematosus in the Italian setting: a cost-effectiveness analysis Open new browser tab
(2013)
Start website main content
(2013)
(2013)
(2013)
(2013)
(2013)
(2013)
(2013)
(2013)
(2013)
(2013)